Navigation Links
Nycomed US Inc. Names Brian A. Markison as Chief Executive Officer
Date:8/1/2011

MELVILLE, N.Y., Aug. 1, 2011 /PRNewswire/ -- Nycomed US Inc. ("Nycomed US") today announced the appointment of Brian A. Markison as President and Chief Executive Officer and member of the Board for what will be the newly created standalone corporation created following the closing of the acquisition of Nycomed A/S by Takeda Pharmaceuticals.  

The Company also appointed Jeff Bailey to the newly created position of Chief Operating Officer, and John Golubieski as the Chief Financial Officer.  

The Company noted that Mr. Markison's more than 30 years of experience in the pharmaceutical industry will be instrumental in driving future growth, which Nycomed US expects to achieve organically as well as through acquisitions, product partnerships and in-licensing opportunities.  

Mr. Markison formerly served as Chairman and Chief Executive Officer of King Pharmaceuticals, which he joined as Chief Operating Officer before being promoted to President and CEO in 2004 and elected to Chairman in 2007.  Prior to King, Mr. Markison held various senior leadership positions at Bristol-Myers Squibb, including President of Oncology / Virology and Oncology Therapeutics Network; President – Neuroscience / Infectious Disease and Dermatology; and Senior Vice President, Operational Excellence and Productivity.  Mr. Markison serves on the Board of Directors of Immunomedics, Inc. and Rosetta Genomics, Ltd., where he also serves as Board Chairman.  Mr. Markison also serves on the Board of Directors for the Komen Foundation for South / Central New Jersey and on the Board of Trustees for the Pennington School. Mr. Markison holds a BS degree from Iona College.

Mr. Markison said, "I am delighted, along with Jeff and John, to join the team at Nycomed US.  This is an exciting time for the company because we have the opportunity to grow aggressively and forge our future as an independent entity.  Jeff and John are great addi
'/>"/>

SOURCE Nycomed US Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Nycomeds Daxas(R) Shows Encouraging Preliminary Results in Phase III COPD Studies
2. Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US
3. Axial Biotech Names New VP of Reimbursement and Regulatory Affairs
4. Wyeth Names Daniel J. McIntyre Vice President, Corporate Communications
5. Genstruct Names Louis Latino VP of Sales
6. Codexis Names Vice President, Intellectual Property
7. New England Peptide Names Director of Chemical Development
8. Horizon Therapeutics Names Robert J. De Vaere Executive Vice President and Chief Financial Officer
9. Board of Directors of Milestone Scientific Names Joseph DAgostino Chief Financial Officer
10. PercSys Names David Auth and Howard Palefsky to Its Board of Directors
11. Sustainable Oils Names Scott Johnson as General Manager, Expands Management Team for Camelina Research and Production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... January 15, 2014 Freeslate, Inc ... today announced that Lupin Limited, one of India’s top ... CM Protégé PharmD System for high throughput solid ... is focused on a wide range of quality, affordable ...
(Date:1/14/2014)... Histogen, Inc., a regenerative medicine company ... under simulated embryonic conditions, today announced that they have ... Inc. for physician-dispensed aesthetic products containing Histogen’s proprietary multipotent ... is an amendment to the existing license between Histogen ...
(Date:1/14/2014)... Md. , Jan. 14, 2014  Organovo announced today ... the National Institutes of Health (NIH) to help scientists ... treatments to patients on a faster timeline. Organovo is ... (NCATS) and the National Eye Institute (NEI) to develop ...
(Date:1/14/2014)... Jan. 14, 2014   Kinaxis ®, provider of RapidResponse ... sales and operations planning ( S&OP ) service, is proud ... , which will be held at the Hilton San Diego ... Kinaxis customer Elisabeth Kaszas , Director of Supply Chain ...
Breaking Biology Technology:Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2
... Encorium Group, Inc. (Nasdaq:  ENCO), (the "Company"), ... conducting studies in over 30 countries for many ... today announced that, on October 20, 2010, it ... (the "Panel") has determined to delist the Company,s ...
... Inc (OTC: OMCM.OB) today announced that it ranked number ... 500 of the fastest growing technology, media, telecommunications, life ... are based on the percentage of fiscal year revenue ... percent during this period. OmniComm,s CEO, Cornelis ...
... even harder in recent years the influenza A virus has ... Reporting their findings in the journal Science, researchers ... not, and how future treatments can defeat the nasty bug no ... are no longer recommended by the CDC for use against flu. ...
Cached Biology Technology:Encorium Announces NASDAQ Panel Decision to Delist Common Stock; Announces Changes to its Board of Directors 2Encorium Announces NASDAQ Panel Decision to Delist Common Stock; Announces Changes to its Board of Directors 3Encorium Announces NASDAQ Panel Decision to Delist Common Stock; Announces Changes to its Board of Directors 4OmniComm Ranks Number 220 on Deloitte's 2010 Technology Fast 500 for Fastest Growing Companies in North America 2OmniComm Ranks Number 220 on Deloitte's 2010 Technology Fast 500 for Fastest Growing Companies in North America 3Putting a bull's-eye on the flu: Detailing influenza's structure for drug targeting 2
(Date:7/10/2014)... from The University of Texas Health Science Center at ... (IYG), a health education program designed to delay sexual ... dating violence behaviors among minority youth. , According to ... of high school youth are victims of physical dating ... percent are victims of emotional dating violence. Previous studies ...
(Date:7/10/2014)... children and teens living with a cardiac pacemaker, a ... quality of life, reports a study in the July ... , the official journal of the Society for ... published by Lippincott Williams & Wilkins , a ... may function as a protective factor against lower health-related ...
(Date:7/10/2014)... National Cancer Research Centre (CNIO) Macromolecular Crystallography Group ... protein called BuD to DNA in order to ... the researcher who led the study, says the ... the instructions contained in the genome to treat ... study is published in the journal Acta ...
Breaking Biology News(10 mins):It's Your Game ... Keep It Real reduces dating violence among minority youth 2For children with pacemakers, 'self-competence' affects quality of life 2CNIO scientists develop technology to redirect proteins towards specific areas of the genome 2
... Munich have developed a new method for visualizing material ... team led by Bert Nickel has, for the first ... organic thin-film solar cells using laser light for localized ... the scientific journal " Advanced Materials ". "We have ...
... has published research this week in a leading science ... they were raised rather than that likely to maximize ... of habitat selection theory. The paper is published ... on June 26 and includes co-authors Michael Palmer, ...
... significantly challenged as production levels fall due to ... the industry,s competitiveness are being sought. The South ... Resources and Energy (DMITRE) has invited VTT Technical ... study that identifies potential routes by which the ...
Cached Biology News:Organic electronics: Imaging defects in solar cells 2Bioeconomy as a solution for South Australia's declining forest industry 2Bioeconomy as a solution for South Australia's declining forest industry 3
...
... The Varian 500-MS LC Ion Trap ... high-throughput LC/MS analysis where sensitivity, reliability ... 500-MS provides a robust platform for ... mass resolution, and mass stability reflect ...
... modular benchtop fume hood ventilates ... safe indoor release of exhaust. ... organic contaminants. Configurations are available ... options include final HEPA filter, ...
... ideal modular cleanroom for biological safety ... require cleanliness (to Class 10/ISO 3) ... to create ultra-smooth surfaces that are ... One-inch radius corners simplify cleaning. Unique ...
Biology Products: